UVE:NYSEUNIVERSAL INSURANCE HOLDINGS INC Analysis
Data as of 2026-05-27 - not real-time
$38.16
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Universal Insurance Holdings is trading at $38.16, comfortably above its immediate support of $37.84 but still below the 20‑day SMA of $39.38, indicating a modest cushion while the 50‑day SMA of $36.64 supports the upside bias. The MACD histogram is negative and the signal line is bearish, and volume has been trending down, suggesting short‑term pressure despite a broader bullish trend direction. The RSI sits near the midpoint at 48, showing no clear overbought or oversold condition, while the 30‑day volatility is elevated at roughly 45%, implying price swings could be sizable. Fundamentally, the stock appears dramatically undervalued – the DCF‑derived fair value of $177 dwarfs the current price, translating to a 15% upside relative to the model and a price‑to‑earnings multiple of 5.6 versus an industry average of 16.6. The company boasts a strong ROE of 38.9%, low debt‑to‑equity (17.2%), and a modest payout ratio of 9.5% that supports the 1.66% dividend yield. Risk factors include high near‑term volatility and decreasing trading volume, but the low beta (~0.5) and solid balance sheet mitigate broader market swings. Overall, the convergence of deep valuation discount, solid cash generation, and sustainable dividend makes UVE a compelling candidate for investors with a medium‑ to long‑term horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above support with bearish MACD
- Decreasing volume signaling limited short‑term buying pressure
- Elevated 30‑day volatility may cause erratic moves
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation gap to DCF fair value
- Strong ROE and low debt supporting earnings stability
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑run upside potential exceeding 15% per model
- Consistent cash flow generation and high profitability margins
- Low beta and defensive insurance sector positioning
Key Metrics & Analysis
Financial Health
Revenue Growth-0.30%
Profit Margin12.22%
P/E Ratio5.6
ROE38.88%
ROA6.06%
Debt/Equity17.15
P/B Ratio1.9
Op. Cash Flow$349.5M
Free Cash Flow$338.5M
Industry P/E16.6
Technical Analysis
TrendBullish
RSI48.2
Support$37.84
Resistance$41.31
MA 20$39.38
MA 50$36.64
MA 200$31.80
MACDBearish
VolumeDecreasing
Fear & Greed Index92.34
Valuation
Fair Value$177.10
Target Price$44.00
Upside/Downside15.30%
GradeUndervalued
TypeValue
Dividend Yield1.66%
Risk Assessment
Beta0.51
Volatility44.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.